ClearBridge Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20,818
Closed -$1.4M 726
2024
Q3
$1.4M Sell
20,818
-14,625
-41% -$1.2M ﹤0.01% 632
2024
Q2
$4.02M Sell
35,443
-3,515
-9% -$444K ﹤0.01% 598
2024
Q1
$5.4M Buy
38,958
+8,936
+30% +$1.12M ﹤0.01% 586
2023
Q4
$3.73M Sell
30,022
-3,218,598
-99% -$329M ﹤0.01% 599
2023
Q3
$303M Sell
3,248,620
-816,928
-20% -$92.1M 0.29% 96
2023
Q2
$522M Sell
4,065,548
-56,084
-1% -$6.78M 0.47% 56
2023
Q1
$479M Sell
4,121,632
-694,251
-14% -$77.7M 0.46% 64
2022
Q4
$545M Sell
4,815,883
-593,091
-11% -$65.1M 0.54% 48
2022
Q3
$436M Sell
5,408,974
-298,536
-5% -$25.3M 0.44% 67
2022
Q2
$425M Buy
5,707,510
+435,194
+8% +$39.7M 0.4% 71
2022
Q1
$674M Buy
5,272,316
+3,968,196
+304% +$434M 0.51% 54
2021
Q4
$175M Sell
1,304,120
-7,876
-0.6% -$1.13M 0.12% 165
2021
Q3
$179M Sell
1,311,996
-12,996
-1% -$1.64M 0.13% 159
2021
Q2
$141M Buy
+1,324,992
New +$127M 0.1% 194

Other funds holding DXCM

ClearBridge Investments's DXCM Position: Q4 2024 in Review

ClearBridge Investments sold out of DexCom (DXCM) in Q4 2024, closing a stake of 20,818 shares — an estimated $1.4M sold.

ClearBridge Investments first reported a position in DXCM in Q2 2021 and held it in 14 quarters. The position peaked at $674M in Q1 2022. 951 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • ClearBridge Investments reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • ClearBridge Investments sold 20,818 DexCom shares in Q4 2024, an estimated $1.4M.
  • ClearBridge Investments first reported a position in DexCom in Q2 2021 and held it in 14 quarters.
  • ClearBridge Investments's DexCom position peaked at $674M in Q1 2022.
  • 951 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on ClearBridge Investments's 13F filing for Q4 2024, filed 12 Feb 2025.